课题基金 / 基金详情

9TH INTERNATIONAL SYMPOSIUM ON CHLAMYDIAL INFECTIONS

9TH INTERNATIONAL SYMPOSIUM ON CHLAMYDIAL INFECTIONS
第九届国际衣原体感染研讨会
批准号:
2636086
负责人:
JULIUS SCHACHTER
金额:
$0.25万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-15 至 1999-06-30

项目摘要

项目成果

JULIUS SCHACHTER的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(改编自摘要):寻求资金支持 参加第九届人类衣原体感染国际研讨会。 沙眼衣原体感染是性传播疾病最常见的原因 传播性疾病通常会导致妇女和 新生儿。在向疾控中心报告的所有值得注意的疾病中,沙眼衣原体 是美国报告的最流行的感染病例,可能 也会增加感染艾滋病毒的风险。这些生物也是 沙眼的病因学是人类可预防的失明的主要原因 世界。肺炎衣原体是一种非常常见的呼吸道疾病。 肺炎衣原体病原菌及其与慢性肺的关系 疾病和冠状动脉疾病显著增加了需求 了解人类衣原体感染。刻画人物形象 扩大衣原体疾病的临床范围已得到促进 通过分子诊断技术的进步。这已经是 与之相辅相成的是最近在阐明 衣原体生物和它们的专性生物之间复杂的相互作用 哺乳动物细胞及其免疫和免疫的分子机制 发病机制。这次会议将与完成 沙眼衣原体和肺炎衣原体基因组序列测定 奋进在第八届国际研讨会上提出并得到支持。 这次会议代表着研究人员在 该领域交流最高质量的研究信息和 不同国家之间的结果比较。考虑到最近的 第九届国际衣原体研究爆炸式增长 人类衣原体感染研讨会将于一九九八年六月举行 吉利和可望提供独特的动力背景 新千年的研究议程。 正在申请30,000美元,以支持30名年轻调查人员 注册费(690美元)和前往旧金山国际机场的旅费 (310美元)。资金大幅增加的原因 与过去几年的请求相比,请求是因为 来自制药行业的补充资金和 以科学/诊断为导向的公司将大幅减少 今年。这是因为抗生素和诊断试剂盒 在临床试验中取得成功的药物现在已经上市,而且越来越少 “争夺市场份额”。沙克特博士一直是校长 前4个国际组织的调查员和主要筹资人 他经常参加研讨会,显然在获得商业支持方面经验丰富。
英文摘要
DESCRIPTION: (adapted from the abstract): Financial support is sought for the 9th International Symposium on Human Chlamydial Infections. Chlamydia trachomatis infections are the most common cause of sexually transmitted diseases often resulting in severe pathology in women and newborns. Of all notable diseases reported to the CDC, C. trachomatis is the most prevalent reported infection in the United States and may also increase the risk of HIV infection. These organisms are also the etiology of trachoma, the leading cause of preventable blindness in the world. C. pneumoniae is recognized as a very common respiratory pathogen and the recent association of C. pneumoniae with chronic lung diseases and coronary artery diseases significantly increases the need for understanding human chlamydial infections. Characterization of the expanded clinical spectrum of chlamydial diseases has been facilitated by advances in molecular techniques for diagnosis. This has been complemented by recent exciting advances in elucidating the sophisticated interplay between chlamydial organisms and their obligate mammalian cells and the molecular mechanisms of immunity and pathogenesis. This meeting will coincide with the completion of the sequencing of the C. trachomatis and C. pneumoniae genomes -- an endeavor proposed and supported at the 8th International Symposium. This meeting represents the most important gathering for researchers in the field to exchange the highest quality research information and comparison of results among different countries. Given the recent explosion of research on chlamydiae, the timing of the 9th International Symposium on Human Chlamydial Infection to be held June, 1998 is propitious and can be expected to uniquely provide the impetus setting the research agenda for the new millennium. $30,000 is being requested for the support of 30 young investigators for registration ($690) and travel to San Francisco International Airport ($310 excursion). The reason for the significant elevation in funds requested, relative to requests in the past years, is because the amount of supplemental funds expected from the pharmaceutical industry and the scientific-oriented/diagnostic companies will be dramatically diminished this year. This is because the antibiotics and diagnostic kits successful in clinical trials are now on the market and there is less "fighting for market share". Dr. Schachter has been the Principal Investigator and principal fund raiser for the previous 4 International Symposia and is clearly experienced in obtaining commercial support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
12th International Symposium on Human Chlamydial Infections
Xlth International Symposium on Human Chlamydial Infections
Xth Int'l Symposium on Human Chlamydial Infection
Azithromycin in Control of Trachoma II
海外基金